MARKET

XPH

XPH

SPDR® S&P Pharmaceuticals ETF
NYSEARCA

Real-time Quotes | Provided by Morningstar

51.91
-0.54
-1.03%
Opening 13:08 06/18 EDT
OPEN
52.10
PREV CLOSE
52.45
HIGH
52.20
LOW
51.84
VOLUME
16.59K
TURNOVER
--
52 WEEK HIGH
56.32
52 WEEK LOW
41.82
TOTAL ASSET
260.13M
YTD YIELD
-4.44%
1D
5D
1M
3M
1Y
5Y
Global interest rates move off of 5,000 year lows: At the Open
Last year marked the the secular low point for inflation and interest rates and 2021 is bringing global rates off the lowest point since 3000 BC, BofA Data Analytics says.In
Seekingalpha · 05/14 12:54
Pharma ETFs in Focus Post Q1 Earnings
Zacks.com · 05/12 08:16
Shock and Tears: Behind Vanguard’s Retreat From China’s Market
Vanguard Group Inc. staff who dialed into a video call from their desks on the 40th floor of the Shanghai World Financial Center last month were expecting a morale-boosting speech from regional head Scott Conking on how the U.S. fund giant would tackle the...
Bloomberg · 04/28 21:01
Fed Strengthens View of Economy While Keeping Rates Near Zero
Federal Reserve Chair Jerome Powell and his colleagues upgraded their assessment of the U.S. economy but said they were not yet ready to consider scaling back pandemic support.
Bloomberg · 04/28 18:00
A $246 Billion Bonanza Means Stock ETF Inflows Already Beat 2020
In less than four months, investors have already poured more cash into ETFs tracking U.S. stocks than they did in all of 2020.
Bloomberg · 04/28 16:30
SEC Punts Long-Awaited Bitcoin ETF Decision to at Least June
Crypto advocates will have to wait a while longer for the U.S. regulator’s verdict on Bitcoin exchange-traded fund approval as applications pile up.
Bloomberg · 04/28 16:18
House Democrats reintroduce bill to lower drug prices
Rep. Frank Pallone, Jr. (D-N.J.) reintroduced H.R. 3, legislation that would allow the federal government to negotiate prescription drug prices.The bill would cap seniors' out-of-pocket costs on prescription drugs to
Seekingalpha · 04/22 19:47
3 Pharmaceutical ETFs That Could Be Due For A Rebound
These three pharmaceutical ETFs have dropped to support, which means they may be about to rebound. Support is a large concentration of buyers who have gathered around the same price level. At support levels, there is more demand for the stock than there is...
Benzinga · 04/15 21:28
More
No Data
Learn about the latest financial forecast of XPH. Analyze the recent business situations of SPDR® S&P Pharmaceuticals ETF through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
No Data
Ratings
Date
Period
Agency
Ratings
08/31/2020
3 Year
Morningstar
08/31/2020
5 Year
Morningstar
08/31/2020
10 Year
Morningstar
  • Performance
  • Asset Allocation
  • Dividend History
Period
Return
Rank in Cat
1-Day
-2.1617%
--
1-Week
0.0432%
--
1-Month
-0.3793%
--
3-Month
0.4992%
--
6-Month
5.0086%
--
YTD
-4.4365%
--
1-Year
25.1785%
--
3-Year
1.2186%
--
5-Year
-3.5232%
--
10-Year
9.8792%
--
Since Inception
9.4359%
--
No Data
No Data
  • All
No Data
Profile
Fund Name
SPDR® S&P Pharmaceuticals ETF
Risk
Medium-high risk
Inception Date
2006-06-19
Benchmark
Dow Jones US Healthcare TR
Advisor Company
State Street Global Advisors Ltd
Custodian
State Street Bank & Trust Co
Manager
Feehily/Schneider/Richardson